Tyra Biosciences Inc (TYRA)
18.23
-0.87
(-4.55%)
USD |
NASDAQ |
May 17, 16:00
18.23
0.00 (0.00%)
After-Hours: 20:00
Tyra Biosciences Total Liabilities (Quarterly): 14.86M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.86M |
| December 31, 2023 | 21.60M |
| September 30, 2023 | 16.19M |
| June 30, 2023 | 11.44M |
| March 31, 2023 | 6.265M |
| December 31, 2022 | 8.352M |
| September 30, 2022 | 8.229M |
| Date | Value |
|---|---|
| June 30, 2022 | 8.265M |
| March 31, 2022 | 7.787M |
| December 31, 2021 | 4.964M |
| September 30, 2021 | 6.239M |
| June 30, 2021 | 162.58M |
| December 31, 2020 | 29.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.964M
Minimum
Dec 2021
162.58M
Maximum
Jun 2021
23.57M
Average
8.352M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 404.74M |
| Shareholders Equity (Quarterly) | 389.88M |